Venclexta (venetoclax)

pCPA File Number: 23527
Negotiation Status:
Active Negotiation
Indication(s):
Calquence, in combination with venetoclex, for the treatment of patients with previously
untreated chronic lymphocytic leukemia (CLL)
Sponsor/Manufacturer:
AbbVie Corporation
CDA-AMC Project Number:
PC0412-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable